Table 2.
QTLR | Gene | Description | Chr | Start | End | Length |
---|---|---|---|---|---|---|
5 | CSTA | Cystatin A (Stefin A) | 1 | 76,253,583 | 76,258,549 | 4967 |
5 | LAG3 | Lymphocyte-activation gene 3 | 1 | 76,676,057 | 76,678,087 | 2031 |
5 | C1S | Complement C1s subcomponent | 1 | 76,859,359 | 76,868,459 | 9101 |
7 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 1 | 102,403,453 | 102,442,746 | 39,294 |
8 | SUPT20H | Spt20 homolog, saga complex component | 1 | 171,574,831 | 171,612,194 | 37,364 |
10 | FLT3 | Fms related tyrosine kinase 3 | 1 | 175,281,894 | 175,309,466 | 27,573 |
11 | RELT | RELT tumor necrosis factor receptor | 1 | 194,551,973 | 194,555,607 | 3635 |
13 | TRANK1 | Tetratricopeptide repeat and ankyrin repeat containing 1 | 2 | 46,537,531 | 46,576,714 | 39,184 |
19 | CTNNA2 | Gallus gallus catenin (cadherin-associated protein), α 2 | 4 | 86,948,459 | 87,057,215 | 108,757 |
29 | HAVCR1 | Hepatitis A virus cellular receptor 1 precursor | 13 | 10,778,915 | 10,785,137 | 6223 |
29 | TIMD4 | T-cell immunoglobulin and mucin domain-containing protein 4 | 13 | 10,789,088 | 10,803,683 | 14,596 |
30 | SOCS1 | Suppressor of cytokine signaling 1 | 14 | 8,935,374 | 8,936,082 | 709 |
32 | TAP1 | Antigen peptide transporter 1 | 16 | 67,623 | 76,124 | 8502 |
32 | IL4I1 | Interleukin 4 induced 1 | 16 | 191,143 | 194,187 | 3045 |
33 | TLR4 | Toll-like receptor 4 precursor | 17 | 3,566,454 | 3,571,907 | 5454 |
33 | BRINP1 | Bmp/retinoic acid inducible neural specific 1 | 17 | 3,985,882 | 4,064,290 | 78,409 |
33 | CD7 | T-cell antigen CD7 | 18 | 3,681,786 | 3,686,083 | 4298 |
35 | TAGLN | Transgelin | 24 | 5,229,236 | 5,232,028 | 2793 |
36 | TREML2 | Triggering receptor expressed on myeloid cells isoform 1 | 26 | 4,693,285 | 4,699,278 | 5994 |
37 | CD79B | CD79b molecule | 27 | 1,622,587 | 1,627,022 | 4436 |
QTLR—ordinal number of the QTLR (Table 1); Chr—chromosome; Start/End—Galgal4 gene coordinates (bp); Length—size of the gene (bp).